| PRD_002203 | Name: | (phenylmethyl) ~{N}-[(12~{S},15~{S},18~{S})-15-(cyclohexylmethyl)-12-(hydroxymethyl)-9,14,17-tris(oxidanylidene)-1,8,13,16,21,22-hexazabicyclo[18.2.1]tricosa-20(23),21-dien-18-yl]carbamate | Formula: | C33 H49 N7 O6 | Definition date: | 2016-05-04 | Last modified: | 2016-05-04 |
|
| PRD_002222 | Name: | N-(3-bromo-4-methoxybenzene-1-carbonyl)-beta-alanyl-3-(8-phenyloctyl)-L-histidyl-L-seryl-O-phosphono-L-threoninamide | Formula: | C38 H53 Br N7 O11 P | Definition date: | 2016-02-24 | Last modified: | 2016-02-24 |
|
| PRD_002200 | Name: | N-benzoyl-L-leucyl-L-leucine | Formula: | C19 H28 N2 O4 | Definition date: | 2016-02-17 | Last modified: | 2016-02-17 |
|
| PRD_002217 | Name: | N-(4-carbamimidoylbenzoyl)-beta-alanyl-L-alpha-aspartyl-L-phenylalanine | Formula: | C24 H27 N5 O7 | Definition date: | 2016-02-03 | Last modified: | 2016-02-04 |
|
| PRD_001259 | Name: | acyclic trypsin inhibitor | Formula: | C67 H108 N18 O19 S2 | Definition date: | 2016-01-13 | Last modified: | 2016-01-13 |
|
| PRD_002208 | Formula: | C43 H66 N6 O8 | Definition date: | 2015-12-16 | Last modified: | 2015-12-16 |
|
| PRD_002211 | Name: | (2~{S})-~{N}-[(1~{R},2~{S})-1-cyano-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepiperidin-3-yl]propan-2-yl]-3-phenyl-2-[[(~{E})-3-phenylprop-2-enoyl]amino]propanamide | Formula: | C27 H30 N4 O4 | Definition date: | 2015-12-09 | Last modified: | 2015-12-09 |
|
| PRD_000929 | Name: | N-acetyl-L-valyl-L-alpha-glutamyl-N-[(2S)-1-carboxy-3-hydroxypropan-2-yl]-L-isoleucinamide | Formula: | C22 H38 N4 O9 | Definition date: | 2015-12-02 | Last modified: | 2015-12-02 |
|
| PRD_002182 | Name: | [amino({3-[(3R,6R,9S,12R,15S,21R,24R,27S,30R,33S,36R,39S)-39-amino-36-(4-ammoniobutyl)-12,33-bis(2-carboxyethyl)-30-(4-hydroxybenzyl)-6-[(1S)-1-hydroxyethyl]-3,21-bis(hydroxymethyl)-27-methyl-9,24-bis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32,35,38-tridecaoxo-1,4,7,10,13,16,19,22,25,28,31,34,37-tridecaazacyclodotetracontan-15-yl]propyl}amino)methylidene]ammonium | Formula: | C63 H106 N18 O21 | Definition date: | 2015-10-28 | Last modified: | 2015-10-28 |
|
| PRD_000841 | Name: | CARBOXYPROPYL-BETA-THIOGALACTOSIDE-LYS-PRO-LEUNH2 | Formula: | C26 H48 N5 O9 S | Definition date: | 2015-09-16 | Last modified: | 2015-09-16 |
|
| PRD_001241 | Name: | (BOC)LPA(B27) PEPTIDE | Formula: | C23 H42 N4 O6 S | Definition date: | 2015-09-09 | Last modified: | 2015-09-09 |
|
| PRD_002106 | Name: | L-alpha-glutamyl-L-isoleucyl-N-[(2S,3S)-4-{[(1S)-1-carboxybutyl]amino}-3-hydroxy-4-oxo-1-(thiophen-2-yl)butan-2-yl]-3-thiophen-2-yl-L-alaninamide | Formula: | C31 H45 N5 O9 S2 | Definition date: | 2015-07-29 | Last modified: | 2015-07-29 |
|
| PRD_000815 | Name: | peptide ACE-THR-VAL-ALC-HIS-H | Formula: | C26 H43 N6 O6 | Definition date: | 2012-12-12 | Last modified: | 2015-07-27 |
|
| PRD_001000 | Name: | peptide ACE-SER-ALA-VAL-LEU-HIS-H | Formula: | C25 H42 N7 O7 | Definition date: | 2012-12-12 | Last modified: | 2015-07-21 |
|
| PRD_002168 | Name: | N-[(benzyloxy)carbonyl]-O-carbamimidamido-L-homoseryl-N-{(3S,4S)-3-hydroxy-6-methyl-1-oxo-1-[(2-phenylethyl)amino]heptan-4-yl}-L-valinamide | Formula: | C34 H51 N7 O7 | Definition date: | 2015-07-15 | Last modified: | 2015-07-15 |
|
| PRD_000990 | Name: | peptide ACE-SER-ALA-VAL-ALC-HIS-H | Formula: | C28 H46 N7 O7 | Definition date: | 2012-12-12 | Last modified: | 2015-06-29 |
|
| PRD_001257 | Name: | para-guanidinomethyl-phenylacetyl-Arg-(3-methylvaline)-Arg-(amidomethyl)benzamidine | Formula: | C36 H59 N15 O4 | Definition date: | 2015-05-27 | Last modified: | 2015-06-22 |
|
| PRD_002146 | Name: | N-[2-(aminomethyl)-5-chlorobenzyl]-1-[(5-methyl-1H-pyrrol-2-yl)carbonyl]-L-prolinamide | Formula: | C19 H23 Cl N4 O2 | Definition date: | 2015-06-17 | Last modified: | 2015-06-17 |
|
| PRD_002174 | Name: | N-(tert-butoxycarbonyl)-L-seryl-L-valyl-N-{(2S)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-L-leucinamide | Formula: | C30 H53 N5 O9 | Definition date: | 2015-06-17 | Last modified: | 2015-06-17 |
|
| PRD_002159 | Name: | N-(4-methoxy-4-oxobutanoyl)-L-alanyl-L-alanyl-N-[(2S)-4-chloro-3-oxo-1-phenylbutan-2-yl]-L-prolinamide | Formula: | C26 H35 Cl N4 O7 | Definition date: | 2015-05-06 | Last modified: | 2015-05-06 |
|
| PRD_002147 | Name: | N-{(2R,4S,5S)-2-benzyl-5-[(tert-butoxycarbonyl)amino]-4-hydroxy-6-phenylhexanoyl}-L-leucyl-L-phenylalaninamide | Formula: | C39 H52 N4 O6 | Definition date: | 2015-03-09 | Last modified: | 2015-03-16 |
|
| PRD_002133 | Name: | (17S,20S,23S,29S)-20-benzyl-29-{[(2S)-2-(methylamino)propanoyl]amino}-19,22,28-trioxo-2,11-dioxa-5,6,7,18,21,27-hexaazapentacyclo[29.2.2.2~12,15~.1~4,7~.0~23,27~]octatriaconta-1(33),4(38),5,12,14,31,34,36-octaene-17-carboxylic acid (non-preferred name) | Formula: | C42 H50 N8 O8 | Definition date: | 2015-03-04 | Last modified: | 2015-03-04 |
|
| PRD_001256 | Name: | bifunctional peptide | Formula: | C39 H43 N5 O5 | Definition date: | 2015-01-14 | Last modified: | 2015-01-14 |
|
| PRD_001172 | Name: | nosiheptide bound form | Formula: | C51 H53 N13 O12 S6 | Definition date: | 2014-12-10 | Last modified: | 2014-12-10 |
|
| PRD_001208 | Name: | Stapled peptide (ACE)NWFNITN(DIV)LW(MK8)I(LYV)KKK | Formula: | C106 H165 N27 O28 P | Description: | MODIFIED FRAGMENT OF HIV GLYCOPROTEIN (GP41) | Definition date: | 2014-12-03 | Last modified: | 2014-12-03 |
|